Meeting
2021 Genitourinary Cancers Symposium
Barriers and facilitators of germline genetic evaluation for prostate cancer.
Authors
Stacy Loeb
New York University Langone Health, New York, NY
Stacy Loeb , Randall Li , Tatiana Sanchez Nolasco , Nataliya Byrne , Heather H. Cheng , Amy Leader , Veda N. Giri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Diagnostics
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 28)
DOI
10.1200/JCO.2021.39.6_suppl.28
Abstract #
28
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Factors related to men’s experience with prostate cancer germline testing.
First Author: Veda N. Giri
Poster
2023 ASCO Genitourinary Cancers Symposium
Barriers to guideline-concordant use of bone modifying agents for prostate cancer.
First Author: Aaron Philip Mitchell
Poster
2022 ASCO Quality Care Symposium
Single-center comparison of cancer genetics referral rates for patients with pancreatic cancer following implementation of a best practice advisory: A quality improvement project.
First Author: Stephanie Rivera Morales
Poster
2022 ASCO Annual Meeting
Patient-reported outcomes among males undergoing prostate cancer germline testing: Interim results from the Prostate Cancer Genetic Risk, Experience, and Support Study (PROGRESS) Registry.
First Author: Veda N. Giri